Global biopharmaceutical company Bristol-Myers Squibb (BMY) reported solid third-quarter financials and is well-positioned to witness immense growth in the upcoming quarters, driven by continued progress in its diverse product pipeline….
Global biopharmaceutical company Bristol-Myers Squibb (BMY) reported solid third-quarter financials and is well-positioned to witness immense growth in the upcoming quarters, driven by continued progress in its diverse product pipeline….